img_5025
FireFly System for Peritoneal Dialysis
Happy elderly couple looking at copyspace

Enhanced Quality of Life

Puracath_04

Patented UV Disinfection Technology

Who Are We?

The PuraCath Medical team is focused on reducing infectious complications associated with catheter connections. Our proprietary UV technology aims to improve the quality of life of healthcare providers and patients by redefining and simplifying the disinfection process prior to infusion. While decreasing dependence on user compliance, our novel and easy-to-use technology seeks an effective treatment to keep users healthy and protected from catheter connection complications.

News

PuraCath Medical to Present Data on FireFly™ Peritoneal Dialysis Connector Disinfecting System during 53rd ERA-EDTA Congress

San Francisco, California (May 12, 2016) – Data being presented will support planned introduction of PuraCath Medical’s technology in the European Union. PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it will present data on its next generation version of the FireFly™ […]

PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings

Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held […]

PuraCath Medical Presents New Research Data during 36th Annual Dialysis Conference

Company presents study on the effectiveness of next-generation version of the FireFly™ Peritoneal Dialysis Connector Disinfecting System Seattle, Washington (February 29, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of […]